Cefprozil Tablet, Film Coated
Product Images NDC 0093-1078

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefprozil (NDC 0093-1078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Cefprozil, showing its molecular components including phenol, amide, thiazolidine ring, and carboxylic acid groups, along with a water molecule (H2O).*

FDA Label Image

Image 2

Label for Cefprozil 250 mg film-coated oral tablets by Teva Pharmaceuticals USA, Inc. The label states the product name, strength, dosage form, and quantity of 100 tablets. It includes directions for storage, standard pharmaceutical warnings, and the National Drug Code (NDC) 0093-1077-01. The design features the Teva logo in blue and white.*

FDA Label Image

Image 3

Label for Cefprozil Tablets USP 500 mg film-coated tablets by Teva Pharmaceuticals USA, Inc. The label includes the NDC code 0093-1078-53 and states that each film-coated tablet contains cefprozil equivalent to 500 mg. The package contains 50 tablets. Storage instructions and manufacturer information are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.